In accordance with our results previous studies showed that CD103+ TIL density has been associated with improved prognosis in patients with non-small cell lung cancer 15, endometrial adenocarcinoma 36, ovarian cancer 37, cervical cancer 16, and bladder cancer 11. The gene discussed is ITGAE; the disease is urinary bladder carcinoma.